Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AtLAS-A: Duloxetine or Escitalopram in Adolescents With Anxiety
NCT04245436Phase 4Recruiting
- Sponsor
- University of Cincinnati
- Start
- Jan 2020
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anxiety disorder and panic disorder comparing Duloxetine with Escitalopram (2 arms). Primary endpoints: Pediatric Anxiety Rating Scale severity score at 24 months and Clinical Global Impression of Severity at 10 weeks. Started Jan 2020; status: recruiting.
02
Drugs
duloxetineescitalopram
03
Conditions
anxiety disorderpanic disorder
Beyond the preview
Go deeper on NCT04245436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04245436.